VYNE Therapeutics

VYNE

NASDAQHealth Care

Income Statement

Total Revenue$501K

Gross Profit$501K

Operating Income$-43.64M

EBITDA$-39.83M

EBIT$-39.83M

Pre-tax Income$-26.73M

Net Income$-39.83M

Cash Equivalent$21.25M

Total Debt$136.75K

Book Value$68.47M

Book Value Per Share4.71

Return on Equity (ROE)-76.48%

Return on Assets (ROA)-59.54%

Return on Invested Capital (ROI)-76.48%

Net Profit Margin-7950.90%

Current Ratio4.35

Quick Ratio4.15

Long-Term Debt / Equity0.00